Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Diego Moran"'
Autor:
William Mantilla, Maríafernanda Gonzalez, Sebastián Rojas, Mariana Borras-Osorio, Nicolas Molano-Gonzalez, Diego Moran, Joaquín Hernando Guerra, Oscar Romero, Isabel Munevar
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEBreast cancer (BC) is the most frequent neoplasm in women in Colombia and is associated with a higher mortality rate than in other countries and regions. Neoadjuvant chemotherapy (NACT) has become a standard treatment in locally advanced BC an
Externí odkaz:
https://doaj.org/article/d7ce038f240b485db91e674d7f900616
For equality-constrained linear mixed-integer programs (MIP) defined by rational data, it is known that the subadditive dual is a strong dual and that there exists an optimal solution of a particular form, termed generator subadditive function. Motiv
Externí odkaz:
http://arxiv.org/abs/2410.21467
Autor:
Yang, James Chih-Hsin, Han, Baohui, De La Mora Jiménez, Emmanuel, Lee, Jong-Seok, Koralewski, Piotr, Karadurmus, Nuri, Sugawara, Shunichi, Livi, Lorenzo, Basappa, Naveen S., Quantin, Xavier, Dudnik, Julia, Ortiz, Diego Moran, Mekhail, Tarek, Okpara, Chinyere E., Dutcus, Corina, Zimmer, Zachary, Samkari, Ayman, Bhagwati, Niyati, Csőszi, Tibor
Publikováno v:
In Journal of Thoracic Oncology June 2024 19(6):941-953
Autor:
William Mantilla, Maria-Fernanda Gonzalez, Sebastian Rojas, Mariana Borras-Osorio, Nicolas Molano-Gonzalez, Joaquin Guerra, Isabel Munevar, Diego Moran
Publikováno v:
Cancer Research. 83:P4-06
Introduction Breast cancer (BC) is the most frequent neoplasm in Colombia, with mortality rate increasing in past decade. The expected 5-year overall survival (OS) is < 80%, being the Latin American country with the worst prognosis. 2 factors related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48597feb0bc698bf1db9b451b30006fa
https://doi.org/10.1158/1538-7445.sabcs22-p4-06-03
https://doi.org/10.1158/1538-7445.sabcs22-p4-06-03
Publikováno v:
Biomédica: revista del Instituto Nacional de Salud, Vol 41, Iss 3, Pp 409-419 (2021)
Biomédica
Biomédica
Primary apocrine carcinoma of the sweat gland is a neoplasm with a very low incidence that may represent a clinical and histological diagnostic challenge, as well as for adequate local, adjuvant, and advanced disease management. The average age of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2196ef8d21f02d71e04638c148ff2681
https://doi.org/10.7705/biomedica.5758
https://doi.org/10.7705/biomedica.5758
Autor:
Alejandra Alarcon, Natalia Castano, Juan Manuel Reyes, Giovanna Matiz, Diego Moran, Ricardo Brugés, Milton Lombana, Ray Manneh, Eduardo Gutierrez
Objective To evaluate progression free survival (PFS) in patients with advanced or metastatic, hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer treated with palbociclib in combination with fulvestrant as second or later lines of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac753ca1524627ff4ae10a79c4269f5
https://doi.org/10.21203/rs.3.rs-1762559/v1
https://doi.org/10.21203/rs.3.rs-1762559/v1
Autor:
Mauricio Luján Piedrahíta, Jorge Armando Egurrola Pedraza, Beatriz Preciado Franco, Diego Moran Ortiz, Camila Lema Calidonio, Mauricio Lema Medina
Publikováno v:
Revista Colombiana de Hematología y Oncología. 7:18-25
Objetivo: Describir los aspectos clínicos, la supervivencia libre de progresión (SLP) y la supervivencia global (SG) en una cohorte de pacientes con cáncer de ovario avanzado y establecer las diferencias entre las tratadas con quimioterapia con o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6bdeb6234e5c043a79376f2a4a210d7
https://doi.org/10.51643/22562915.77
https://doi.org/10.51643/22562915.77
Autor:
Diego Moran-Landa, Maria del Rosario Damian, Pedro Miguel Portillo Mendoza, Carlos Sotomayor-Beltran
Publikováno v:
International Journal of Advanced Computer Science and Applications. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e4553ca7a35632fe600664dfcb6427a
https://doi.org/10.14569/ijacsa.2022.0131092
https://doi.org/10.14569/ijacsa.2022.0131092
Autor:
Mauricio Lujan, Mauricio Lema, Beatriz Preciado, Camila Lema, Jorge Egurrola, Andres Felipe Cardona Zorrilla, Diego Mauricio Gonzalez, William Armando Mantilla, Luis Pino, Gustavo Rojas, Diego Andres Gomez-Abreo, Isabel Munevar, Raimundo Manneh, Ray Manneh Kopp, Jose F. Lobaton, Esteban Calle, Mariana Borras, Ivan Camilo Triana, Mateo Pineda, Diego Moran Ortio
Publikováno v:
Journal of Clinical Oncology. 40:e21094-e21094
e21094 Background: Nivolumab is a human programmed death receptor-1 (PD-1) blocking antibody, used as treatment option in patients with advanced non-small cell lung cancer (NSCLC). We assessed the nivolumab efficacy in terms of survival and response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58139caa0b77a496adac30b5e24c8e5e
https://doi.org/10.1200/jco.2022.40.16_suppl.e21094
https://doi.org/10.1200/jco.2022.40.16_suppl.e21094
Autor:
Diego Moran, Pol Vandenbroucke, Nilima A Kshirsagar, Ashok Sethia, Gregory Utz, Nithya J Gogtay, Shirsendu Sarkar
Publikováno v:
Research and Reports in Tropical Medicine
Nilima A Kshirsagar,1 Nithya J Gogtay,1 Diego Moran,2 Gregory Utz,3 Ashok Sethia,4 Shirsendu Sarkar,5 Pol Vandenbroucke6 1Seth G S Medical College and KEM Hospital, Mumbai, India; 2Hospital San Andrés de Tumaco, Narino, Colombia; 3US Naval Medical R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e8ae0755ae3815344f23181d0a01559
https://doi.org/10.2147/rrtm.s129741
https://doi.org/10.2147/rrtm.s129741